Carticept Medical closed a $10 million financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc.
The Alpharetta, Ga.-based company said it will use the proceeds to fund the commercial launch of its Navigator computer-controlled drug delivery system. The device uses ultrasound guidance to deliver medications for joint pain.
Cambridge Heart Inc. (OTC:CAMH) plans to bring its HearTwave II Microvolt T-Wave Alternans (MTWA) test for sudden cardiac arrest to Singapore through an exclusive distribution deal with EO Medical Pte Ltd.
The deal hinges on the MTWA device winning regulatory approval in Singapore, which the Tewksbury, Mass.-based company expects within the next 6 to 9 months.
MONT-SAINT-GUIBERT, Belgium, September 22, 2011 /PRNewswire/ —
The Belgian biotechnology company, Cardio3 BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, announced today that it has established a subsidiary, Cardio3 BioSciences, Inc. in Rochester, Minnesota.
MassDevice Network
@MassDevice
LinkedIn
YouTube